Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Choong, Nicholas W ⁱ   Mauer, Ann M ^a,j   Haraf, Daniel C ^a   Ferguson, Mark K ^a   Sandler, Alan B ^b   Kesler, Kenneth A ^c   Fishkin, Paul A S ^d   Ansari, Rafat H ^e   Wade III, James ^f   Krauss, Stuart A ^g   Sciortino, David F ^h   Posner, Mitchell C ^a   Kocherginsky, Masha ^a   Hoffman, Philip C ^a   Szeto, Livia ^a   Vokes, Everett E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d Illinois Cancer Care   (United States)

^e Michiana Hematology Oncology   (United States)

^f Cancer Care Specialists of Central Illinois   (United States)

^g Strauss Cancer Centre   (United States)

^h GUTHRIE RESEARCH INSTITUTE   (United States)

ⁱ MEDICAL COLLEGE OF WISCONSIN   (United States)

^j ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

more..

Author keywords

Docetaxel; Esophagus cancer; Radiotherapy

Indexed keywords

CISPLATIN; CREATININE; DOCETAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; DIARRHEA; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGOGASTRECTOMY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INFECTION; INOPERABLE CANCER; LEUKOCYTE; LOWER ESOPHAGUS SPHINCTER CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIXED TUMOR; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PERICARDITIS; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RADIATION DERMATITIS; RADIATION DOSE; RADIATION INDUCED EMESIS; RADIATION INJURY; SCLERODERMA; SEPSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; UNDIFFERENTIATED CARCINOMA;

EID: 84655176759     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9658-1     Document Type: Article

References (44)

1. JS Cooper MD Guo A Herskovic JS Macdonald JA Martenson Jr M Al-Sarraf 1999 Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group JAMA 281 17 1623 1627 (Pubitemid 29211772)
2. TN Walsh N Noonan D Hollywood A Kelly N Keeling TP Hennessy 1996 A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 7 462 467 (Pubitemid 26269945)
3. JF Bosset M Gignoux JP Triboulet E Tiret G Mantion D Elias 1997 Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 337 3 161 167 (Pubitemid 27306287)
4. JS Macdonald SR Smalley J Benedetti SA Hundahl NC Estes GN Stemmermann 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 10 725 730
5. RA Malthaner RK Wong RB Rumble L Zuraw 2004 Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis BMC Med 2 1 35
6. AJ Graham FM Shrive WA Ghali BJ Manns SC Grondin RJ Finley 2007 Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis Ann Thorac Surg 83 4 1257 1264 (Pubitemid 46440778)
7. V Gebski B Burmeister BM Smithers K Foo J Zalcberg J Simes 2007 Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 3 226 234 (Pubitemid 46291702)
8. P Das N Fukami JA Ajani 2006 Combined modality therapy of localized gastric and esophageal cancers J Natl Compr Canc Netw 4 4 375 382 (Pubitemid 44265357)
9. B Kavanagh M Anscher K Leopold M Deutsch E Gaydica R Dodge 1992 Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990 Int J Radiat Oncol Biol Phys 24 4 633 642
10. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359(9319):1727-33.
11. J Jin Z Liao Z Zhang J Ajani S Swisher JY Chang 2004 Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery Int J Radiat Oncol Biol Phys 60 2 427 436 (Pubitemid 39233461)
12. DP Kelsen R Ginsberg TF Pajak DG Sheahan L Gunderson J Mortimer 1998 Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med 339 27 1979 1984 (Pubitemid 29024130)
13. S Law M Fok S Chow KM Chu J Wong 1997 Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial J Thorac Cardiovasc Surg 114 2 210 217
14. E Ancona A Ruol S Santi S Merigliano VC Sileni H Koussis 2001 Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone Cancer 91 11 2165 2174 (Pubitemid 32476382)
15. M Creane CB Seymour S Colucci C Mothersill 1999 Radiobiological effects of docetaxel (Taxotere): a potential radiation sensitizer Int J Radiat Biol 75 6 731 737 (Pubitemid 29298105)
16. O Pradier M Rave-Frank J Lehmann E Lucke O Boghun CF Hess 2001 Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CaSki) Int J Cancer 91 6 840 845 (Pubitemid 32178654)
17. AI Einzig D Neuberg SC Remick DD Karp PJ O'Dwyer JA Stewart 1996 Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293 Med Oncol 13 2 87 93 (Pubitemid 27019943)
18. K Muro T Hamaguchi A Ohtsu N Boku K Chin I Hyodo 2004 A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer Ann Oncol 15 6 955 959 (Pubitemid 39004353)
19. B Schull GV Kornek K Schmid M Raderer M Hejna A Lenauer 2003 Effective combination chemotherapy with bimonthly docetaxel and cisplatin with or without hematopoietic growth factor support in patients with advanced gastroesophageal cancer Oncology 65 3 211 217 (Pubitemid 37508513)
20. AM Mauer GA Masters DJ Haraf PC Hoffman SM Watson HM Golomb 1998 Phase I study of docetaxel with concomitant thoracic radiation therapy J Clin Oncol 16 1 159 164 (Pubitemid 28041594)
21. Beahrs OH, American Joint Committee on Cancer, American Cancer Society, National Cancer Institute (U.S.). Manual for staging of cancer. 4th ed. Philadelphia: Lippincott; 1992.
22. PF Brunsvig R Hatlevoll R Berg G Lauvvang K Owre M Wang 2005 Weekly docetaxel with concurrent radiotherapy in locally advanced non-small cell lung cancer: a phase I/II study with 5 years' follow-up Lung Cancer 50 1 97 105 (Pubitemid 41297476)
23. MI Koukourakis N Bahlitzanakis M Froudarakis A Giatromanolaki V Georgoulias S Koumiotaki 1999 Concurrent conventionally fractionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma Br J Cancer 80 11 1792 1796 (Pubitemid 29389634)
24. A Font A Arellano J Fernandez-Llamazares D Casas J Boix J Cardenal 2007 Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancer Clin Transl Oncol 9 3 177 182
25. T Ruhstaller L Widmer JC Schuller A Roth V Hess W Mingrone 2009 Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02) Ann Oncol 20 9 1522 1528
26. BD Minsky TF Pajak RJ Ginsberg TM Pisansky J Martenson R Komaki 2002 INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy J Clin Oncol 20 5 1167 1174 (Pubitemid 34177421)
27. H Onishi K Kuriyama M Yamaguchi T Komiyama S Tanaka T Araki 2003 Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis Lung Cancer 40 1 79 84 (Pubitemid 36344070)
28. AG Taghian SI Assaad A Niemierko I Kuter J Younger R Schoenthaler 2001 Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel J Natl Cancer Inst 93 23 1806 1811 (Pubitemid 33150453)
29. CD Wright JC Wain TJ Lynch NC Choi ML Grossbard RW Carey 1997 Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study J Thorac Cardiovasc Surg 114 5 811 815 discussion 6
30. N Choi SD Park T Lynch C Wright M Ancukiewicz J Wain 2004 Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study Int J Radiat Oncol Biol Phys 60 1 111 122 (Pubitemid 39165475)
31. RM Abou-Jawde T Mekhail DJ Adelstein LA Rybicki PJ Mazzone MA Caroll 2005 Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer Chest 128 1 250 255 (Pubitemid 40994481)
32. JI Geh AM Crellin R Glynne-Jones 2001 Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer Br J Surg 88 3 338 356 (Pubitemid 32238694)
33. P Flamen A Lerut E Van Cutsem W De Wever M Peeters S Stroobants 2000 Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma J Clin Oncol 18 18 3202 3210
34. EI Heath BA Burtness RF Heitmiller R Salem L Kleinberg JP Knisely 2000 Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus J Clin Oncol 18 4 868 876 (Pubitemid 30106619)
35. AA Meluch FA Greco JR Gray M Thomas VM Sutton JL Davis 2003 Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial Cancer J 9 4 251 260
36. DW Kim CD Blanke H Wu Y Shyr J Berlin RD Beauchamp 2007 Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer Int J Radiat Oncol Biol Phys 67 2 397 404 (Pubitemid 46108316)
37. SG Swisher JA Ajani R Komaki JC Nesbitt AM Correa JD Cox 2003 Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer Int J Radiat Oncol Biol Phys 57 1 120 127 (Pubitemid 36959747)
38. H Wang J Ryu D Gandara RJ Bold S Urayama M Tanaka 2007 A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer J Thorac Oncol 2 2 153 157 (Pubitemid 47181345)
39. A Herskovic K Martz M al-Sarraf L Leichman J Brindle V Vaitkevicius 1992 Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 24 1593 1598
40. M al-Sarraf K Martz A Herskovic L Leichman JS Brindle VK Vaitkevicius 1997 Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study J Clin Oncol 15 1 277 284 (Pubitemid 27020584)
41. M Suntharalingam J Moughan LR Coia MJ Krasna L Kachnic DG Haller 2003 The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 patterns of care study Int J Radiat Oncol Biol Phys 56 4 981 987 (Pubitemid 36794029)
42. LR Coia BD Minsky BA Berkey MJ John D Haller J Landry 2000 Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 patterns of care study J Clin Oncol 18 3 455 462 (Pubitemid 30078526)
43. L Bedenne P Michel O Bouche C Milan C Mariette T Conroy 2007 Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 J Clin Oncol 25 10 1160 1168 (Pubitemid 46640561)
44. M Stahl M Stuschke N Lehmann HJ Meyer MK Walz S Seeber 2005 Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 23 10 2310 2317 (Pubitemid 46218723)